Page 96 - Bio News Today

Hosking Partners LLP lowered its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 17.1% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 52,290 shares of the medical research company’s stock after selling 10,762 shares during the period. […]

It's the final month for Owensboro's Towne Square Mall in its present form. Gulfstream Chief Operating Officer...

A new solar energy development is coming to Henderson County. Officials with Nucor Corp. say they have a new P...

Here. yet the thing that was most, i the focus was on deforestation. that aspect hasnt actually entered the final accord of this summit. yes. that was quite _ final accord of this summit. i2; that was quite disappointing for us because we are aiming to have at least a common goal for zero deforestation in the amazon bio. the declaration just like deforestation in the amazon bio. the declarationjust like on deforestation in the amazon bio. the declaration just like on the national goes, that is r...

Bio-Rad Laboratories (NYSE:BIO – Free Report) had its price objective raised by Royal Bank of Canada from $522.00 to $524.00 in a report published on Friday morning, Benzinga reports. Royal Bank of Canada currently has an outperform rating on the medical research company’s stock. A number of other research firms also recently commented on BIO. […]

*Owensboro, KY -* The committee for Empty Bowls of Owensboro KY is excited to announce that there will be two ...

Beginning Tuesday, August 8, Ernie Davis & Sons Mechanical, Inc. will close Salem Drive to through traffic...

Due to a staff shortage, Daviess County Animal Care and Control will be closed on Monday. According to their F...

Bio-Rad Laboratories (NYSE:BIO – Get Free Report) issued its quarterly earnings results on Thursday. The medical research company reported $3.00 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.55 by $0.45, Briefing.com reports. Bio-Rad Laboratories had a positive return on equity of 4.10% and a negative net margin of 7.01%. The […]

Bio-Rad Laboratories (NYSE:BIO – Get Free Report) posted its quarterly earnings results on Thursday. The medical research company reported $3.00 earnings per share for the quarter, topping analysts’ consensus estimates of $2.55 by $0.45, Briefing.com reports. Bio-Rad Laboratories had a negative net margin of 7.01% and a positive return on equity of 4.10%. The business […]